Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen

Patient Educ Couns. 2018 Nov;101(11):1982-1989. doi: 10.1016/j.pec.2018.06.019. Epub 2018 Jun 30.

Abstract

Objective: The objective of this study was to explore the perceived advantages and disadvantages of oral anticoagulant therapies (OAT), and the trade-offs patients make in choosing therapy and adhering to their drug regimen.

Methods: Five focus group sessions were conducted across Europe among patients with atrial fibrillation to identify the most important factors impacting OAT's value and adherence.

Results: The most frequently identified barriers to OAT were lack of knowledge; poor patient-physician relationships; distraction due to employment or social environment; prior bleeding event(s) or the fear of bleeding; and changes in routine. Factors identified as promoting adherence included patients' personality, motivation, attitudes, and medication-taking habits and routines, as well as good quality health services. Inconvenient aspects of vitamin-K antagonists, such as regular blood monitoring and diet restrictions, were not reported to influence adherence, but may trigger patients to switch to direct oral anticoagulants.

Conclusion: Most patients reported that a mixture of modifiable and non-modifiable factors helps them to take their drugs as prescribed. Individual patients' particular needs and preferences regarding OAT vary.

Practice implications: OAT adherence can be promoted if therapies are tailored to patients' needs and preferences. Patients should be supported to share their preferences with their clinician.

Keywords: Adherence; Anticoagulation; Atrial fibrillation; Focus group; Patient perspective; Stroke; Values.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage*
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / drug therapy*
  • Blood Coagulation / drug effects*
  • Female
  • Focus Groups
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Male
  • Medication Adherence*
  • Middle Aged
  • Perception
  • Physician-Patient Relations
  • Qualitative Research
  • Risk Assessment
  • Social Support
  • Stroke / blood
  • Stroke / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants